Companies: 10,638     total market cap: NZ$234.502 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
AbbVie
ABBV
#26
Rank
NZ$691.65 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$391.34
Share price
-1.15%
Change (1 day)
34.26%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2025 : -NZ$4.5 Billion

According to AbbVie's latest financial reports the company has -NZ$4.5 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$5.96 B-63.72%
2023-12-31$NZ$16.44 B-39.62%
2022-12-31$NZ$27.22 B20.48%
2021-12-31$NZ$22.59 B24.5%
2020-12-31$NZ$18.15 B-249.59%
2019-12-31$-NZ$12.14 Billion-3.63%
2018-12-31$-NZ$12.6 Billion-275.45%
2017-12-31$NZ$7.17 B7.23%
2016-12-31$NZ$6.69 B16.11%
2015-12-31$NZ$5.76 B159.25%
2014-12-31$NZ$2.22 B-59.33%
2013-12-31$NZ$5.46 B33.71%
2012-12-31$NZ$4.08 B-73.26%
2011-12-31$NZ$15.28 B-24.89%
2010-12-31$NZ$20.35 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$161.14 B-3,681.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B-815.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B-1,017.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.65 B-470.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$37.14 B-925.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$31.51 B-800.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.65 B-914.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
NZ$79.57 B-1,868.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$5.19 B-215.57%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com